Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
21 Gennaio 2025 - 11:00PM
Edgar (US Regulatory)
Exhibit 1
JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge
and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments
to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint
filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and
accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information
is inaccurate.
DATED: January 21, 2025
|
NIRLAND LIMITED |
|
|
|
|
By: |
/s/ David Rowland |
|
Name: |
David Rowland |
|
Title: |
Director |
|
|
|
|
STOCKTON LIMITED |
|
|
|
|
By: |
/s/ David Rowland |
|
Name: |
David Rowland |
|
Title: |
Director |
|
|
|
|
THE ROWLAND MASTER TRUST |
|
|
|
|
By: |
Dovet Limited, its trustee |
|
|
|
|
By: |
/s/ Harley Rowland |
|
Name: |
Harley Rowland |
|
Title: |
Director |
|
|
|
|
DOVET LIMITED |
|
|
|
|
By: |
/s/ Harley Rowland |
|
Name: |
Harley Rowland |
|
Title: |
Director |
Grafico Azioni Conduit Pharmaceuticals (NASDAQ:CDTTW)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Conduit Pharmaceuticals (NASDAQ:CDTTW)
Storico
Da Feb 2024 a Feb 2025